407100002: Gefitinib (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Transferase inhibitor\Phosphotransferase inhibitor\Protein kinase inhibitor\...

\Epidermal growth factor receptor inhibitor\Gefitinib (substance)

\Protein-tyrosine kinase inhibitor\Gefitinib (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Antineoplastic agent (substance)\Epidermal growth factor receptor inhibitor\Gefitinib (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinazoline (substance)\Gefitinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2150930012 Gefitinib (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2158721012 Gefitinib en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

364001000195114 gefitinib it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

814241000172112 géfitinib fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

3335281001000116 Gefitinib de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Gefitinib (substance)	Is a	Antineoplastic agent (substance)	false	Inferred relationship	Some
Gefitinib (substance)	Is a	Protein-tyrosine kinase inhibitor	true	Inferred relationship	Some
Gefitinib (substance)	Is a	Quinazoline (substance)	true	Inferred relationship	Some
Gefitinib (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Protein-tyrosine kinase inhibitor (disposition)	true	Inferred relationship	Some
Gefitinib (substance)	Is a	produit chimique catégorisé selon sa fonction	false	Inferred relationship	Some
Gefitinib (substance)	Is a	Enzyme inhibitor	false	Inferred relationship	Some
Gefitinib (substance)	Is a	Epidermal growth factor receptor inhibitor	true	Inferred relationship	Some
Gefitinib (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Epidermal growth factor receptor inhibitor	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Gefitinib 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gefitinib (substance)	Inferred relationship	Some
Iressa 250mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gefitinib (substance)	Inferred relationship	Some
Product containing gefitinib (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gefitinib (substance)	Inferred relationship	Some	1
Gefitinib 250 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Gefitinib (substance)	Inferred relationship	Some	1
Gefitinib 250 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Gefitinib (substance)	Inferred relationship	Some	1
Gefitinib 250 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Gefitinib (substance)	Inferred relationship	Some	1
Gefitinib-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gefitinib (substance)	Inferred relationship	Some	1
Gefitinib only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gefitinib (substance)	Inferred relationship	Some	1
Product containing only gefitinib in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Gefitinib (substance)	Inferred relationship	Some	1

This concept is not in any reference sets